- Home
- ZAPP vs BMRA Comparison
ZAPP vs BMRA Comparison
Compare ZAPP & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZAPP
- BMRA
- Stock Information
- Founded
- ZAPP 2017
- BMRA 1971
- Country
- ZAPP Thailand
- BMRA United States
- Employees
- ZAPP N/A
- BMRA N/A
- Industry
- ZAPP Motor Vehicles
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ZAPP Consumer Discretionary
- BMRA Health Care
- Exchange
- ZAPP Nasdaq
- BMRA Nasdaq
- Market Cap
- ZAPP 8.3M
- BMRA 7.4M
- IPO Year
- ZAPP N/A
- BMRA N/A
- Fundamental
- Price
- ZAPP $1.79
- BMRA $0.34
- Analyst Decision
- ZAPP
- BMRA
- Analyst Count
- ZAPP 0
- BMRA 0
- Target Price
- ZAPP N/A
- BMRA N/A
- AVG Volume (30 Days)
- ZAPP 89.5K
- BMRA 336.7K
- Earning Date
- ZAPP 11-19-2024
- BMRA 10-15-2024
- Dividend Yield
- ZAPP N/A
- BMRA N/A
- EPS Growth
- ZAPP N/A
- BMRA N/A
- EPS
- ZAPP N/A
- BMRA N/A
- Revenue
- ZAPP N/A
- BMRA $5,509,000.00
- Revenue This Year
- ZAPP N/A
- BMRA N/A
- Revenue Next Year
- ZAPP $53,347.33
- BMRA N/A
- P/E Ratio
- ZAPP N/A
- BMRA N/A
- Revenue Growth
- ZAPP N/A
- BMRA 1.74
- 52 Week Low
- ZAPP $0.70
- BMRA $0.24
- 52 Week High
- ZAPP $19.10
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- ZAPP 29.06
- BMRA 50.48
- Support Level
- ZAPP $1.62
- BMRA $0.34
- Resistance Level
- ZAPP $2.08
- BMRA $0.44
- Average True Range (ATR)
- ZAPP 0.19
- BMRA 0.04
- MACD
- ZAPP 0.00
- BMRA -0.00
- Stochastic Oscillator
- ZAPP 24.25
- BMRA 37.07
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.